Nuelle™, a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women, announces today its Indiegogo campaign to raise awareness and funding for the company’s first product launch Fiera® Arouser for Her™.
In the US, roughly 46% of all American women, aged 18 – 70 have a sexual concern. Among committed couples, intimacy is important for both the health of the relationship and personal wellbeing. Sex, however, is often a tough subject to broach with partners, health care professionals and friends alike. Through its partnership with Indiegogo, Nuelle aims to normalize the conversation about women’s sexual wellbeing and the impact on quality of life, while educating couples about Fiera® Arouser for Her™ and its proven technology to scientifically enhance arousal and desire, naturally.
Co-created with women and healthcare professionals to bring back excitement to connect sexually with her partner, Nuelle’s Fiera® Arouser for Her™ is the first wearable intimacy enhancer used in advance of a sexual experience that is proven to ignite arousal and increase desire among women. In a study (after four weeks of using Fiera), 87% of women said they felt “in the mood” for sex and 83% enjoyed engaging in sex.*
To view the multimedia release go to:
http://www.multivu.com/players/English/7750851-nuelle-indiegogo-fiera-arouser-for-her/
Fergie, six-time Grammy Award winner and Avon spokesperson, was a special guest at the eighth annual Los Angeles-area Avon Walk for Breast Cancer in Santa Barbara, CA, on September 11-12. The Avon Walk raised more than $6.4 million to advance access to care and breast cancer research, and attracted more than 2,800 participants from 45 states and Canada, including 322 breast cancer survivors.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42977/
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53530-gen-probe-progensa-pca3-prostate-cancer-psa
Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/
“Explore Your Treatment Options,” a new multimedia ad campaign announced today by the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) and the Ad Council, encourages patients to become more informed about their options before choosing a treatment for a health condition or illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/50583/
Johnson & Johnson today announced the launch of Every Mother, Every Child, a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations’ April 2010 call for a renewed effort to achieve the Millennium Development Goals (MDGs) of reducing mortality in women and children by 2015.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/jnj/46066/
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced plans to launch its new epilepsy-focused educational website, www.Epilog.us, at the American Epilepsy Society (AES) annual meeting, December 3-5, 2011. The new website will be featured at the Upsher-Smith booth (# 102) and marks an important landmark in the Company’s commitment to the epilepsy community.
To view Multimedia News Release go to http://www.multivu.com/mnr/53440-upsher-smith-launches-new-epilepsy-focused-website
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that subscribers to Epilog.us can now access the latest information related to Practice Management & Epilepsy at http://www.Epilog.us. Led by Dr. Aatif Husain, Director of the Clinical Neurophysiology Fellowship, Professor of Medicine, Division of Neurology, Duke University Medical Center, and Dr. John Stern, Co‐Director of the Seizure Disorder Center and Professor of Neurology at the David Geffen School of Medicine at UCLA, areas of focus include: the importance of billing code accuracy; commonly utilized billing codes in epilepsy and neurology; and epilepsy quality measures from the American Academy of Neurology (AAN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/58062-upsher-smith-epilog-us-practice-management-epilepsy-resources-available
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, http://www.Epilog.us, has been expanded to include thought-leader commentary on issues related to Epilepsy and Comorbidities. The newly updated website will make its debut at the 64th Annual American Academy of Neurology Meeting in New Orleans on April 23 – 26, 2012, at the Upsher-Smith exhibit, booth number 128.
TO view Multimedia News Release, go to http://www.multivu.com/mnr/55934-upsher-smith-expands-epilog-us-on-epilepsy-comorbidities
Non-profit Enroll America, the nation’s largest health care enrollment coalition, is working with the Ad Council to encourage women to sign up for health insurance under the Affordable Care Act during the next open enrollment period, which runs from November 15, 2014 through February 15, 2015.
To raise awareness, Enroll America is working with the Ad Council to continue its successful “Take Care, People” integrated public service advertising (PSA) campaign encouraging the uninsured, particularly women, to enroll. According to the U.S. Department of Labor, women make 80% of the health care decisions for their families. Women are also 47% more likely than their male counterparts to share information about health care with their friends, family and community. Lack of awareness is a critical issue among women, however, with 79% of those in the Enroll America study saying they do not know enough about the new law.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7368551-enroll-america-ad-council-second-affordable-care-act-open-enrollment-period-begins/
The American College of Emergency Physicians is dedicated to advancing emergency care and to advocating on behalf emergency physicians and the 124 million emergency patients cared for each year. To accomplish this, ACEP is using a new tool to communicate. This TV portal can be embedded on websites and blogs and will automatically be updated as new content comes available!
To view Multimedia News Release, go to http://www.multivu.com/players/English/50856-emergency-medicine-action-fund/
